Atlas Trials

Ironwood Pharmaceuticals, Inc.

25 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ironwood Pharmaceuticals, Inc.

RecordFirmDate
A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (NCT05740007)Ironwood Pharmaceuticals, Inc.2023-03-28
A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects (NCT05362695)Ironwood Pharmaceuticals, Inc.2022-05-17
A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers (NCT05188261)Ironwood Pharmaceuticals, Inc.2022-01-18
A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome (NCT03931785)Ironwood Pharmaceuticals, Inc.2019-05-01
Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers (NCT03856970)Ironwood Pharmaceuticals, Inc.2019-03-11
Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) (NCT03561883)Ironwood Pharmaceuticals, Inc.2018-09-06
A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (NCT03573908)Ironwood Pharmaceuticals, Inc.2018-06-20

Track Ironwood Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.